Brought to you by 
Chiroscience licenses US Chirocaine rights to Purdue
14 Feb 2000
Executive Summary
Chiroscience Group PLC has exclusively licensed US rights to its Chirocaine (levobupivacaine) long-acting anesthetic and pain management therapeutic to Purdue Pharma LP. Maruishi Pharmaceutical Co. currently holds an exclusive Japanese license to the drug, and this month Abbott Laboratories acquired rights in the rest of the world.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Chiroscience licenses US Chirocaine rights to Purdue
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice